We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Immunoassay Determines Response to Low-Dose Aspirin Therapy

By LabMedica International staff writers
Posted on 14 Aug 2008
A newly available test measures a person's response to low-dose aspirin therapy. More...
The test uses a random urine sample, and is not subject to variables associated with blood sampling.

Low-dose aspirin therapy is routinely prescribed to millions of Americans for cardiovascular disease prevention. The effects of aspirin in reducing blood (platelet) "stickiness" vary considerably from patient to patient. In fact, conservative estimates suggest that aspirin resistance exists in about 25% of the population. Individuals who do not respond to aspirin are more than three times more likely to die from heart disease than those that respond well to aspirin.

Platelets are small blood cells that stick together to form blood clots and control bleeding. They produce a chemical called thromboxane to attract other platelets and increase their stickiness. Aspirin inhibits the production of thromboxane by platelets, therefore reducing their stickiness and limiting the size of clots. The new test, which is called Aspirin Response Testing (ART), measures the level of thromboxane production in apparently healthy individuals.

ART is an enzyme-linked immunoassay (ELISA) that measures the levels of 11-dehydro thromboxane B2 (11dhTxB2) in human urine. It reflects in vivo production of thromboxane A2, which is the target of aspirin therapy. Clinical studies have shown that elevated levels of 11dhTxB2 correlate to increased cardiovascular risk.

Aspirin response is highly assay-specific, meaning that a patient may not test positive for aspirin resistance with tests that stimulate platelet aggregation in vitro via other, less specific pathways. ART is an in vivo test that specifically measures stable thromboxane metabolites. The results are reported in pg of 11dhTxB2 per mg of creatine to standardize results to urine concentration.

SpectraCell Laboratories (Houston, TX, USA) offers ART testing as well as Lipoprotein Particle Profile (LPP) and Functional Intracellular Analysis (FIA) testing. Unlike traditional cholesterol tests, LPP directly measures the number of several classes of lipoprotein particles providing an accurate assessment of cardiovascular risk. The FIA provides an assessment of a patient's nutritional status.

Related Links:
SpectraCell Laboratories

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gastrointestinal Panel
Xpert® GI Panel
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.